Neomel (Melatonin)

Melatonin, the active ingredient in Neomel, is a melatonin receptor agonist presented as an oral formulation for oral use. It is used to help regulate sleep‑wake cycles and is indicated for insomnia, jet lag and other sleep‑related disorders in adults. GNH USA supplies Neomel as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Neomel acts on the melatonin pathway to support normal circadian rhythm and sleep onset. - Insomnia: helps reduce time to fall asleep and improve sleep quality. - Jet lag: assists in adjusting the internal clock after rapid time‑zone travel. - Shift‑work sleep disorder: promotes sleep during daytime rest periods. - Delayed sleep phase disorder: advances the timing of sleep onset. - General sleep disturbances: supports overall sleep maintenance and continuity.

Neomel is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate pain often resolving without intervention. - Dizziness: transient sensation of light‑headedness. - Daytime sleepiness: occasional residual drowsiness after nighttime dosing. - Nausea: mild stomach upset that usually subsides. - Vivid dreams: unusual or intense dreaming during sleep. - Mild gastrointestinal discomfort: occasional abdominal cramping.

Serious or Rare Side Effects: - Allergic reactions: rash, itching, swelling, or difficulty breathing. - Severe skin eruption: Stevens‑Johnson‑type rash requiring medical attention. - Mood changes: depression or increased anxiety in susceptible individuals. - Seizures: rare occurrence, particularly in patients with a seizure disorder. - Hormonal effects: alterations in reproductive hormone levels with prolonged high‑dose use.

Neomel should be used with awareness of specific safety considerations. - Pregnancy: consult a healthcare professional before use. - Breastfeeding: discuss potential risks with a physician. - Children and adolescents: use only under medical supervision. - Anticoagulant therapy: monitor for increased bleeding tendency. - Operating machinery: avoid tasks requiring alertness if residual drowsiness occurs. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Melatonin can interact with several medicines, requiring attention to dosage and monitoring.

Major Interactions (Avoid): - Warfarin (anticoagulant): may increase bleeding risk. - Cyclosporine (immunosuppressant): can alter melatonin metabolism. - Fluvoxamine (CYP1A2 inhibitor): may raise melatonin plasma levels.

Moderate Interactions (Monitor Closely): - Benzodiazepines or other CNS depressants: additive sedative effect. - Oral hypoglycemic agents: potential for enhanced glucose lowering. - Combined oral contraceptives: possible reduction in contraceptive efficacy.